Literature DB >> 3041360

Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management.

S Pahwa1.   

Abstract

The causative agent of acquired immunodeficiency syndrome is a retrovirus, human T lymphotropic virus type III/lymphadenopathy-associated virus, now known as human immunodeficiency virus (HIV). Infection of children with HIV results in a wide spectrum of clinical manifestations, ranging from asymptomatic to symptomatic, with the severest disease forms including neurologic deterioration, opportunistic infections and malignancy. This virus infects preferentially T cells bearing the CD4 receptors and also seems to exhibit preference for the central nervous system. The predominant route of infection in children is transplacental, and most affected children are infected at the time of birth. For women who give birth to infants with congenital infection with HIV, the main risk factor is intravenous drug abuse; a smaller percentage of these women acquire the infection via sexual contact and a few are infected via blood transfusions. Estimates for the incidence of transmission of the virus from an infected mother to her offspring vary from about 20 to 70%. Infection in most children and adults is documented by serologic testing, inasmuch as almost all infected people are HIV antibody-positive. Mothers of congenitally affected children are always HIV antibody-positive and also frequently have immune abnormalities. Women who give birth to infected children may, however, be asymptomatic in 50% of instances or more. Because antibodies to HIV are predominantly of the IgG class, they cross the placenta. All infants born to infected women therefore acquire passively transferred antibodies to HIV irrespective of whether or not the infants are infected with the virus itself. These passively transferred antibodies may sometimes persist for as long as 15 months. Thus in infants and children under 15 months of age in the absence of symptoms, the only definitive way to establish diagnosis is by viral isolation or viral antigen detection. Clinically the HIV-infected children can be divided into two groups, symptomatic and asymptomatic. Among the symptomatic group the main diagnostic specific features are: (1) opportunistic infection, e.g. with Pneumocystis carinii pneumonia; (2) interstitial pneumonitis with respiratory distress resulting from lymphocytic interstitial pneumonitis; (3) microcephaly and other neurologic abnormalities; (4) recurrent bacterial infections.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3041360

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  How frequent and how early does the neurological involvement in HIV-positive children occur? Preliminary results of a prospective study.

Authors:  A M Laverda; P Cogo; A Condini; C Cattelan; C Giaquinto; S Cozzani; E Ruga; F Viero; A De Rossi; A Del Mistro
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 2.  The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV.

Authors:  Paolo Palma; Margaret McManus; Nicola Cotugno; Salvatore Rocca; Paolo Rossi; Katherine Luzuriaga
Journal:  Lancet HIV       Date:  2020-05       Impact factor: 12.767

Review 3.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

4.  Response to superantigen stimulation in peripheral blood mononuclear cells from children perinatally infected with human immunodeficiency virus and receiving highly active antiretroviral therapy.

Authors:  Thomas W McCloskey; Viraga Haridas; Lucy Pontrelli; Savita Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

5.  Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immune deficiency syndrome. Plain film and CT observations.

Authors:  J K Amorosa; R W Miller; L Laraya-Cuasay; S Gaur; R Marone; L Frenkel; J L Nosher
Journal:  Pediatr Radiol       Date:  1992

6.  Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children.

Authors:  Monica Kharbanda; Thomas W McCloskey; Rajendra Pahwa; Mei Sun; Savita Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

7.  Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy.

Authors:  Margaret McManus; Jennifer Henderson; Anita Gautam; Robin Brody; Eric R Weiss; Deborah Persaud; Eric Mick; Katherine Luzuriaga
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

8.  Brainstem Auditory Evoked Potential in HIV-Positive Adults.

Authors:  Carla Gentile Matas; Alessandra Giannella Samelli; Rosanna Giaffredo Angrisani; Fernanda Cristina Leite Magliaro; Aluísio C Segurado
Journal:  Med Sci Monit       Date:  2015-10-20

Review 9.  Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review.

Authors:  Silvere D Zaongo; Feng Sun; Yaokai Chen
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 10.  Zika virus: epidemiology, clinical aspects, diagnosis, and control of infection.

Authors:  Ahmad Karkhah; Hamid Reza Nouri; Mostafa Javanian; Veerendra Koppolu; Jila Masrour-Roudsari; Sohrab Kazemi; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-30       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.